These doctors are concerned you won’t be able to afford the medicines they want to prescribe you.
A national group of more than 140,000 physicians on Tuesday joined a coalition dedicated to reversing the growing trend of high-cost specialty drugs, which are being blamed for straining the finances of patients, insurance plans and public health coverage programs.
The move by the American College of Physicians came a day after the Obama administration said it is asking Congress to give it power to negotiate with drugmakers over the prices of costly prescription medication provided to Medicare beneficiaries.
“The pricing of specialty drugs lacks transparency and rationality,” said ACP President David Fleming as he announced that his group of internists, the second-largest physician association in the U.S., was joining the Campaign for Sustainable Rx Pricing.
Read More